Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QNX Software Systems, a subsidiary of BlackBerry Limited, is a leading provider of real-time operating systems (RTOS) and foundational software for the healthcare and medical device industries. The company's technology is a critical component in life-critical systems, powering approximately 80% of the world's leading surgical robotics platforms and a wide range of devices including patient monitors, ventilators, and infusion pumps. QNX offers safety-certified solutions, such as the QNX OS for Safety (certified to IEC 62304 Class C), which provide the reliability and security required for regulated medical environments. As the industry shifts toward software-defined medical devices, QNX provides the essential infrastructure for high-performance computing, low-latency response, and robust cybersecurity. Headquartered in Ottawa, Canada, QNX is a cornerstone of the modern medtech ecosystem, enabling manufacturers to accelerate the development of complex, life-saving technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QNX.